In vitro assessment of the further potential for development of fluoroquinolone resistance in Neisseria meningitidis

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 5, 2005, Pages 1753-1760

  Shultz, Tiffany R ^a,b   White, Peter A ^b   Tapsall, John W ^a,b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ASPARAGINE; ASPARTIC ACID; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; GLUTAMIC ACID; GLYCINE; ISOLEUCINE; LYSINE; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; THREONINE; TROVAFLOXACIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BACTERIUM MUTANT; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; DNA GYRASE; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; MUTATION; NEISSERIA MENINGITIDIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 18244392178     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.5.1753-1760.2005     Document Type: Article

References (26)

1. Antignac, A., P. Kriz, G. Tzanakaki, J-M Alonso, and M-K Taha. 2001. Polymorphisms of Neisseria meningitidis penA gene associated with reduced susceptibility to penicillin. J. Antimicrob. Chemother. 47:285-296.
2. Belland, R. J., S. G. Morrison, C. Ison, and W. M. Huang. 1994. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol. Microbiol. 14:371-380.
3. Björkman, J., I. Nagaev, O. G. Berg, D. Hughes, and D. I. Anderson. 2000. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science. 287:1479-1482.
4. Communicable Disease Network of Australia. 2001. Guidelines for the early clinical and public health management of meningococcal disease in Australia. Commonwealth Department of Health and Aged Care, Canberra, Australia.
5. Deguchi, T., M. Yasuda, M. Asano, K. Tada, H. Iwata, H. Komeda, T. Ezaki, I. Saito, and Y. Kawada. 1995. DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 39:561-563.
6. Deguchi, T., M. Yasuda, M. Nakano, S. Ozeki, T. Ezaki, I. Saito, and Y. Kawada. 1996. Quinolone-resistant Neisseria gonorrhoeae: Correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles. Antimicrob. Agents Chemother. 40:1020-1023.
7. Dewi, B. E., S. Akira, H. Hayashi, and W. Ba-Thein. 2004. High occurrence of simultaneous mutations in target enzyme and MtrRCDE efflux system in quinolone-resistant Neisseria gonorrhoeae. Sex. Transm. Dis. 31:353-359.
8. Eliopoulos, G. M. 2004. Quinolone resistance mechanisms in pneumococci. Clin. Infect. Dis. 38(Suppl. 4):S350-356.
9. Kaneko, A., J. Sasaki, M. Shimadzu, A. Kanayama, T. Saika, and I. Kobayashi. 2000. Comparison of gyrA and parC mutations and resistance levels among fluoroquinolone-resistant isolates and laboratory-derived mutants of oral streptococci. J. Antimicrob. Chemother. 45:771-775.
10. Lindback, E., M. Rahman, S. Jalal, and B. Wretlind. 2002. Mutations in gyrA, gyrB, parC and parE in quinolone-resistant strains of Neisseria gonorrhoeae. APMIS 110:651-657.
11. Orus, P., and M. Vinas. 2001. Mechanisms other than penicillin-binding protein-2 alterations may contribute to moderate penicillin resistance in Neisseria meningitidis. Inter. J. Antimicrob. Agents 18:113-119.
12. Pidcock, L. J. V. 1998. Fluoroquinolone resistance. Br. Med. J. 317:1029-1030.
13. Ropp, P. A., M. Hei, M. Olesky, and R. A. Nicholas. 2002. Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus, penC, are required for high-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 46:769-777.
14. Roquette-Loughlin, C., S. A. Dunham, M. Kuhn, J. T. Balthazar, and W. W. Shafer. 2003. The NorM efflux pump of Neisseria gonorrhoeae and Neisseria meningitidis recognizes antimicrobial cationic compounds. J. Bacteriol. 185: 1101-1106.
15. Shigemura, K., T. Shirakawa, H. Okada, N. Hinata, B. Acharya, S. Kinoshita, T. Kofuku, M. Kawabata, S. Kamidono, S. Arakawa, and A. Gotoh. 2004. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan. Sex. Transm. Dis. 31:180-184.
16. Shultz, T. R., J. W. Tapsall, and P. A. White. 2001. Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC. Antimicrob. Agents Chemother. 45:734-738.
17. Stein, D. C., R. J. Danaher, and T. M. Cook. 1991. Characterization of a gyrB mutation responsible for low-level nalidixic acid resistance in Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 35:622-626.
18. Tanaka, M., H. Nakayama, M. Haraoka, T. Saika, I. Kobayashi, and S. Naito. 2000. Susceptibilities of Neisseria gonorrhoeae isolates containing amino acid substitutions in GyrA, with or without substitutions in ParC, to newer fluoroquinolones and other antibiotics. Antimicrob. Agents Chemother. 44:192-195.
19. Tapsall, J. W., E. A. Phillips, and Y. M. Cossins. 1984. Penicillin sensitivity of gonococci in Australia: the development of an Australian gonococcal surveillance programme. Br. J. Vener. Dis. 60:226-230.
20. Tapsall, J. W., T. R. Shultz, and E. A. Phillips. 1992. Characteristics of Neisseria gonorrhoeae isolated in Australia showing decreased sensitivity to Quinolone antibiotics. Pathology. 24:27-31.
21. The W.H.O. Western Pacific Gonococcal Antimicrobial Surveillance Programme. 2002. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the W.H.O. Western Pacific Region, 2001. Commun. Dis. Intelligence. 26:541-545.
22. Trees, D. L., A. L. Sandul, W. L. Whittington, and J. S. Knapp. 1998. Identification of novel mutation patterns in the parC gene of ciprofloxacin-resistant isolates of Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 42:2103-2105.
23. Trees, D. L., A. L. Sandul, V. Peto-Mesola, M. R. Aplasca, H. B. Leng, W. L. Whittington, and J. S. Knapp. 1999. Alterations within the quinolone resistance-determining regions of GyrA and ParC of Neisseria gonorrhoeae isolated in the Far East and the United States. Inter. J. Antimicrob. Agents. 12:325-332.
24. Tunkel, A. R., and W. M. Scheld. 1993. Treatment of bacterial meningitis, p. 381-393. In: Hooper, D. S., and J. S. Wolfson (ed.), Quinolone antimicrobial agents, 2nd ed., American Society for Microbiology, Washington, D.C.
25. Tzanakaki, G., C. C. Blackwell, J. Ktremastinou, C. Kallergi, G. Kouppari, and D. M. Weir. 1992. Antibiotic sensitivities of Neisseria meningitidis isolates from patients and carriers in Greece. Epidemiol. Infect. 108:449-455.
26. Weigel, L. M., G. J. Anderson, R. R. Facklam, and F. C. Tenover. 2001. Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 45:3517-3523.